SCHEMBL521811

SCHEMBL521811

Cn1cc(Br)c(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3645313 0.82 NPSR1 (0.40)
SCHEMBL461974 0.74
SCHEMBL19039335 0.74
Hydrochloric Acid SCHEMBL16060751 0.72 ALDH1A1 (0.38)
SCHEMBL671995 0.72
SCHEMBL1724597 0.72
SCHEMBL9779253 0.72
SCHEMBL17382261 0.70
SCHEMBL1357520 0.70
SCHEMBL20689264 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010141817-A1 HETEROARYL-SUBSTITUTED SPIROCYCLIC DIAMINE UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO claimed
EP-2164493-A2 HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE Janssen Pharmaceutica, N.V. (BE) 2010-03-24 EP claimed
US-20090062294-A1 HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE JANSSEN PHARMACEUTICA NV (BE) 2009-03-05 US claimed
WO-2008153752-A2 HETEROARYL-SUBSTITUTED UREA MODULATORS OF FATTY ACID AMIDE HYDROLASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-12-18 WO claimed
US-20250304537-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME REPARE THERAPEUTICS INC. (CA) 2025-10-02 US disclosed
CN-119894872-A Heteroarenes, pharmaceutical compositions containing heteroarenes, and methods of use thereof 修复治疗公司 2025-04-25 CN disclosed
EP-4526293-A1 HETEROARENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME Repare Therapeutics Inc. (CA) 2025-03-26 EP disclosed
US-20250042889-A1 3CLPRO PROTEASE INHIBITOR SHANGHAI QILU PHARMACEUTICAL RESEARCH AND DEVELOPMENT CENTRE LTD. (CN) 2025-02-06 US disclosed
WO-2024254527-A1 METHODS OF TREATING INFLAMMATORY DISEASES INTERLINE THERAPEUTICS, INC. (US) 2024-12-12 WO disclosed
US-20240400555-A1 Compounds, Compositions and Methods for Attenuation of Mammalian Translation of C-MYC or N-MYC Proteins of the MYC Proto-Oncogene Family of BHLH Transcription Factors INITIAL THERAPEUTICS, INC. (US) 2024-12-05 US disclosed
WO-2024226875-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR ATTENUATION OF MAMMALIAN TRANSLATION OF C-MYC OR N-MYC PROTEINS OF THE MYC PROTO-ONCOGENE FAMILY OF BHLH TRANSCRIPTION FACTORS INITIAL THERAPEUTICS, INC. (US) 2024-10-31 WO disclosed
US-20240317753-A9 Tricyclic heterocycles MERCK PATENT GMBH (DE) 2024-09-26 US disclosed
CN-1033642-C Process for the preparation of substituted N-aryl-1, 2, 4-triazolopyrimidine-2-sulfonamides DOWELANCO (US) 1996-12-25 CN disclosed
CN-1134223-A Method for controling needless plant DOWELANCO (US) 1996-10-30 CN disclosed
CN-1071429-A The N-aryl-1,2 that replaces, the preparation method of 4-triazolo pyrimidine-2-sulphonamide DOWELANCO (US) 1993-04-28 CN disclosed
EP-0537611-A1 Process for the preparation of substituted N-(aryl)-1,2,4-triazolopyrimidine-2-sulfonamides DOWELANCO (US) 1993-04-21 EP disclosed
EP-0537423-A1 N-pyrazolyl-1,2,4-triazolo(1,5-c)pyrimidine-2-sulfonamide herbicides DowElanco (US) 1993-04-21 EP disclosed
US-5201938-A N-pyrazolyl-1,2,4-triazolo[1,5-c]pyrimidine-2-sulfonamide herbicides DOWELANCO (US) 1993-04-13 US disclosed
CN-1068824-A N-pyrazolyl-1, 2, 4-triazolo [1, 5-c ] pyrimidine-2-sulfonamides as herbicides DOWELANCO (US) 1993-02-10 CN disclosed
US-5177206-A Process for the preparation of substituted N-(aryl)-1,2,4-triazolopyrimidine-2-sulfonamides DOWELANCO (US) 1993-01-05 US disclosed